SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Karol E. Watson, MD, PhD

Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
Los Angeles, CA

Title
: Evolving Strategies for Cardiovascular Risk Reduction: Beyond Statin Therapy
Activity/Course #:
: NCME310
Cost:
: Free
Release/Start Date:
: Oct 26 2016
Expiration Date:
: Oct 25 2017
Topics:
: Cardiovascular
Target Audience:
: Primary Care Providers
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 0
Hardware/Software Requirements:
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care 2016 conference. The topic of this webcast is Evolving Strategies for Cardiovascular Risk Reduction: Beyond Statin Therapy and features Karol E. Watson, MD, PhD.
Learning Objective(s):
After completing this program participants should be able to:
  1. Discuss the benefits of LDL-C lowering with pharmacologic therapies that improve cardiovascular outcomes
  2. Define the appropriate use of non-statin medications in addition to statin therapy
  3. Discuss the role of anti-PCSK9 monoclonal antibody therapy in LDL-C reduction to achieve cardiovascular risk reduction
  4. Recognize and develop appropriate treatment strategies for special populations (women, elderly, ethnic minorities) that would benefit from lipid lowering therapy


This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hours of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Karol E. Watson, MD, PhD, Speaker, has the following relationship to disclose: Consultant – Amgen, GSK, Merck, Quest.

Jan Basile, MD, Planning Committee, has the following relationship to disclose: Grant/Research support - The National Heart, has the following relationship to disclose: Lung, and Blood Institute (Sprint); Consultant - Grant/Research support - The National Heart, Lung, and Blood Institute (Sprint), Eli-Lilly (Rewind); Speakers Bureau - Arbor, Amgen, Janssen.

Phillip B. Duncan, MD, Planning Committee, has the following relationship to disclose: Advisory Board - Arbor; Speakers Bureau - Novartis.

Icilma V. Fergus, MD, FACC, Planning Committee, has no relationships to disclose.

Robert Gillespie, MD, FACC, FASE, FASNC, Planning Committee, has the following relationship to disclose: Investor - Relypsa.

Barbara Hutchinson, MD, PhD, FACC, Planning Committee, has no relationships to disclose.

Priscilla Pemu, MD, MSCR, FACP, Planning Committee, has the following relationship to disclose: Employee – Morehouse School of Medicine, Piedmont Medical Care Corporation.

David Smith, MD, Planning Committee, has the following relationship to disclose: Speaker - Arbor, CardioDx.

Mark Thompson, MD, Planning Committee, has the following relationship to disclose: Speaker/Training - Novartis.

Laurence O. Watkins, MD, MPH, FACC, Planning Committee, has the following relationship to disclose: Patient Care - Healthy Heart Center, Inc.

Gregg Sherman, MD
, Course Director, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by is supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.